Mach7 Cuts Deployment Time with $1.7M AMRADNET Deal

Major Contract Accelerates Mach7’s US Expansion

Mach7 Technologies (ASX:M7T) has landed a significant five-year subscription contract with American Radiologist Network Inc. (AMRADNET), a leading US teleradiology provider. The deal, initially valued at A$1.7 million, is based on a minimum volume of 675,000 imaging studies per year, with expectations to exceed one million studies over the contract term. This agreement marks a notable step in Mach7’s efforts to deepen its penetration into the US healthcare imaging market.

What sets this contract apart is the dramatic reduction in deployment time. Mach7 anticipates first productive use (FPU) within 45 days, a stark contrast to its usual 12-month implementation cycle. This acceleration underscores an ongoing commercial transformation within Mach7, including restructuring of sales and services teams and the removal of operational silos aimed at streamlining customer onboarding.

AMRADNET’s Growth Fuels Demand for Scalable Imaging Solutions

AMRADNET’s SaaS-based Radiology Informatics Portal connects US board-certified radiologists with a broad spectrum of healthcare facilities, from hospitals to outpatient and urgent care centres. Since its 2004 founding, the company has expanded beyond acute care into cardiology, neurology, and telemedicine services, reflecting a rapidly growing clinical footprint. Mach7’s eUnity Viewer platform, designed for high-volume, fast-paced imaging environments, aligns well with AMRADNET’s scalable ambitions.

Mach7 CEO Teri Thomas highlighted the synergy, noting that the swift transition from evaluation to expected FPU demonstrates both AMRADNET’s operational focus and the robustness of Mach7’s platform. This contract builds on Mach7’s recent strategic milestones, including its first Flamingo Architecture subscription deal and a positive cash flow turnaround earlier this year, which indicated progress in stabilising its commercial operations and product positioning first Flamingo contract.

Operational Efficiency Gains Drive Faster Sales Cycle

The shortened sales cycle and deployment timeframe reflect Mach7’s broader efforts to reset its commercial engine following a challenging period marked by revenue declines and widening losses earlier in 2026. The company’s strategic reset, including cost management and sales team restructuring, appears to be bearing fruit in converting pipeline opportunities into contracts more swiftly and efficiently revenue slide and loss surge.

While the initial contract value is modest relative to Mach7’s overall revenue, the volume-based nature of the licence and the potential for scaling with AMRADNET’s growth could provide a meaningful recurring revenue stream. The deal also signals Mach7’s ability to support high-volume, SaaS-based imaging workflows, a critical capability as enterprise imaging evolves toward integrated, cloud-enabled solutions.